Suppr超能文献

新出现的毛霉目真菌阿波枝霉的分子系统发育多样性:三个新物种的提议

Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species.

作者信息

Alvarez Eduardo, Stchigel Alberto M, Cano Josep, Sutton Deanna A, Fothergill Annette W, Chander Jagdish, Salas Valentina, Rinaldi Michael G, Guarro Josep

机构信息

Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Reus, Spain.

出版信息

Rev Iberoam Micol. 2010 Jun 30;27(2):80-9. doi: 10.1016/j.riam.2010.01.006. Epub 2010 Mar 4.

Abstract

BACKGROUND

Apophysomyces is a monotypic genus belonging to the order Mucorales. The species Apophysomyces elegans has been reported to cause severe infections in immunocompromised and immunocompetent people. In a previous study of Alvarez et al.(3) [J Clin Microbiol 2009;47:1650-6], we demonstrated a high variability among the 5.8S rRNA gene sequences of clinical strains of A. elegans.

MATERIAL AND METHODS

We performed a polyphasic study based on the analysis of the sequences of the histone 3 gene, the internal transcribed spacer region of the rDNA gene, and domains D1 and D2 of the 28S rRNA gene, as well as by evaluation of some relevant morphological and physiological characteristics of a set of clinical and environmental strains of A. elegans.

RESULTS AND CONCLUSIONS

We have demonstrated that A. elegans is a complex of species. We propose as new species Apophysomyces ossiformis, characterised by bone-shaped sporangiospores, Apophysomyces trapeziformis, with trapezoid-shaped sporangiospores, and Apophysomyces variabilis, with variable-shaped sporangiospores. These species failed to assimilate esculin, whereas A. elegans was able to assimilate that glycoside. Amphotericin B and posaconazole are the most active in vitro drugs against Apophysomyces.

摘要

背景

附肢霉属是毛霉目下的一个单型属。据报道,雅致附肢霉可在免疫功能低下和免疫功能正常的人群中引起严重感染。在之前阿尔瓦雷斯等人的研究(3)[《临床微生物学杂志》2009年;47:1650 - 6]中,我们证明了雅致附肢霉临床菌株的5.8S rRNA基因序列存在高度变异性。

材料与方法

我们基于对组蛋白3基因序列、rDNA基因的内转录间隔区以及28S rRNA基因的D1和D2结构域的分析,以及对一组雅致附肢霉临床和环境菌株的一些相关形态学和生理学特征的评估,进行了一项多相研究。

结果与结论

我们证明了雅致附肢霉是一个复合种。我们提出将具有骨状孢子囊孢子的骨形附肢霉、具有梯形孢子囊孢子的梯形附肢霉和具有可变形状孢子囊孢子的可变附肢霉作为新物种。这些物种不能同化七叶苷,而雅致附肢霉能够同化该糖苷。两性霉素B和泊沙康唑是体外抗附肢霉活性最强的药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验